1-4 of 4
Max S. Topp
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT341: AFM13: an antigen specific immunotherapy for the treatment of CD30+ malignancies: Results of first-in-man study in relapsed/refractory (R/R) Hodgkin lymphoma (HL)

Achim Rothe, Katrin S. Reiners, Max S. Topp, Anas Younes, Bastian von Tresckow, Horst Dieter Hummel, Joerg Kessler, Miroslav Ravic, Jens-Peter Marschner, Elke Pogge von Strandmann, Andreas Engert
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): CT341.
https://doi.org/10.1158/1538-7445.AM2014-CT341
Published: 01 October 2014
View article titled, Abstract CT341: AFM13: an antigen specific immunotherapy for the treatment of CD30+ malignancies: Results of first-in-man study in relapsed/refractory (R/R) Hodgkin lymphoma (HL)
Journal Articles

Abstract 4572: The CD30/CD16A RECRUIT TandAb AFM13 activates patient NK cells resulting in specific tumor cell killing.

Achim Rothe, Max S. Topp, Anas Younes, Uwe Reusch, Stefan Knackmuss, Erich Rajkovic, Dennis A. Eichenauer, Horst Hummel, Katrin S. Reiners, Markus Dietlein, Joerg Kessler, Miroslav Ravic, Christian Hucke, Eugene Zhukovsky, Elke Pogge von Strandmann, Andreas Engert
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4572.
https://doi.org/10.1158/1538-7445.AM2013-4572
Published: 15 April 2013
View article titled, Abstract 4572: The CD30/CD16A RECRUIT TandAb AFM13 activates patient NK cells resulting in specific tumor cell killing.
Journal Articles

CD28 Costimulation Provided through a CD19-Specific Chimeric Antigen Receptor Enhances In vivo Persistence and Antitumor Efficacy of Adoptively Transferred T Cells

Claudia M. Kowolik, Max S. Topp, Sergio Gonzalez, Timothy Pfeiffer, Simon Olivares, Nancy Gonzalez, David D. Smith, Stephen J. Forman, Michael C. Jensen, Laurence J.N. Cooper
Journal: Cancer Research
Cancer Res (2006) 66 (22): 10995–11004.
https://doi.org/10.1158/0008-5472.CAN-06-0160
Published: 15 November 2006
View article titled, CD28 Costimulation Provided through a CD19-Specific Chimeric Antigen Receptor Enhances <em>In vivo</em> Persistence and Antitumor Efficacy of Adoptively Transferred T Cells
Open the PDF for CD28 Costimulation Provided through a CD19-Specific Chimeric Antigen Receptor Enhances <em>In vivo</em> Persistence and Antitumor Efficacy of Adoptively Transferred T Cells in another window
Journal Articles

Recombinant Human Interleukin 4 Has Antiproliferative Activity on Human Tumor Cell Lines Derived from Epithelial and Nonepithelial Histologies

Max S. Topp, Christos A. Papadimitriou, Florian Eitelbach, Michael Koenigsmann, Elisabeth Oelmann, Birgit Koehler, Dorothea Oberberg, Birgit Reufi, Harald Stein, Eckhard Thiel, Wolfgang E. Berdel
Journal: Cancer Research
Cancer Res (1995) 55 (10): 2173–2176.
Published: 01 May 1995
View article titled, Recombinant Human Interleukin 4 Has Antiproliferative Activity on Human Tumor Cell Lines Derived from Epithelial and Nonepithelial Histologies
Open the PDF for Recombinant Human Interleukin 4 Has Antiproliferative Activity on Human Tumor Cell Lines Derived from Epithelial and Nonepithelial Histologies in another window